Does VEDOLIZUMAB Cause Progressive multifocal leukoencephalopathy? 25 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 25 reports of Progressive multifocal leukoencephalopathy have been filed in association with VEDOLIZUMAB (ENTYVIO). This represents 0.0% of all adverse event reports for VEDOLIZUMAB.
25
Reports of Progressive multifocal leukoencephalopathy with VEDOLIZUMAB
0.0%
of all VEDOLIZUMAB reports
2
Deaths
7
Hospitalizations
How Dangerous Is Progressive multifocal leukoencephalopathy From VEDOLIZUMAB?
Of the 25 reports, 2 (8.0%) resulted in death, 7 (28.0%) required hospitalization, and 1 (4.0%) were considered life-threatening.
Is Progressive multifocal leukoencephalopathy Listed in the Official Label?
Yes, Progressive multifocal leukoencephalopathy is listed as a known adverse reaction in the official FDA drug label for VEDOLIZUMAB.
What Other Side Effects Does VEDOLIZUMAB Cause?
Off label use (21,017)
Colitis ulcerative (13,455)
Crohn's disease (9,759)
Drug ineffective (8,424)
Diarrhoea (7,493)
Abdominal pain (6,401)
Fatigue (5,477)
Haematochezia (5,215)
Frequent bowel movements (4,527)
Arthralgia (4,028)
What Other Drugs Cause Progressive multifocal leukoencephalopathy?
NATALIZUMAB (1,668)
RITUXIMAB (1,647)
CYCLOPHOSPHAMIDE (782)
PREDNISONE (606)
PREDNISOLONE (439)
TACROLIMUS (438)
METHOTREXATE (428)
DOXORUBICIN (421)
MYCOPHENOLATE MOFETIL (414)
VINCRISTINE (376)
Which VEDOLIZUMAB Alternatives Have Lower Progressive multifocal leukoencephalopathy Risk?
VEDOLIZUMAB vs VELAGLUCERASE ALFA
VEDOLIZUMAB vs VELCADE
VEDOLIZUMAB vs VELETRI
VEDOLIZUMAB vs VELIPARIB
VEDOLIZUMAB vs VEMURAFENIB